Ziia A V, Sokolov G B, Firsov A A
Antibiot Med Biotekhnol. 1987 Mar;32(3):223-7.
Pharmacokinetics of rifampicin studied in 15 patients after its intravenous administration in a dose of 10 mg/kg was described by a two-compartment model. The drug levels in serum and urine were determined with a chemical method. At the moment of the infusion discontinuation the maximum drug levels in serum averaged to 14.05 micrograms/ml. The mean values of the total clearance, distribution of the kinetic volume and half-lives were 93.2 ml/(h X kg), 1016.1 ml/kg and 8.1 h respectively. Cumulative excretion of the total rifampicin within 24 hours amounted to 19.4 per cent of the administered dose, the proportions of the main metabolite (25-O-desacetyl rifampicin) and intact rifampicin being equal to 29 and 71 per cent respectively. The renal and nonrenal clearance of rifampicin amounted to 14.2 and 79 ml/(h X kg) respectively.
对15名患者静脉注射10mg/kg剂量的利福平后的药代动力学进行了研究,其符合二室模型。采用化学方法测定血清和尿液中的药物水平。输液停止时,血清中药物最高水平平均为14.05微克/毫升。总清除率、动力学容积分布和半衰期的平均值分别为93.2毫升/(小时×千克)、1016.1毫升/千克和8.1小时。24小时内利福平的总累积排泄量占给药剂量的19.4%,主要代谢产物(25-O-去乙酰利福平)和完整利福平的比例分别为29%和71%。利福平的肾清除率和非肾清除率分别为14.2和79毫升/(小时×千克)。